1. Repositorio Digital Universidad De Las Américas
  2. Facultad de Ciencias de la Salud
  3. Escuela de Medicina Veterinaria y Zootecnia
  4. Medicina Veterinaria y Zootecnia
Por favor, use este identificador para citar o enlazar este ítem: http://dspace.udla.edu.ec/handle/33000/10974
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.advisorJaramillo Cisneros, Francisco Javier-
dc.creatorMorales Torres, Ivette Carolina-
dc.date.accessioned2019-05-22T22:16:32Z-
dc.date.available2019-05-22T22:16:32Z-
dc.date.issued2019-
dc.identifier.citationMorales Torres, I. C. (2019). Evaluación de la glucemia con el método de espectrofotometría en pacientes caninos sanos bajo un protocolo anestésico basado en xilacina en la Clínica Veterinaria Vetcarecenter (Tesis de pregrado). Universidad de las Américas, Quito.es_ES
dc.identifier.otherUDLA-EC-TMVZ-2019-02-
dc.identifier.urihttp://dspace.udla.edu.ec/handle/33000/10974-
dc.descriptionXylazine is a drug widely used drug in veterinary medicine, especially in large animals such as horses and cattle. Nowadays, this drug is being used substantially in small animals medicine, such as cats and dogs. However, there is not enough information about xylazines’ effects in healthy canines. The aim of this paper, was to determine if xylazine’s effect, as a member of the alpha 2 adrenergic family, creates a hyperglycemic effect in healthy canines. This is a non-randomized, crossover clinical study, using an Intention-to-Treat analysis, the population was 115 canines in 11 months, and the sample were 10 healthy canines that underwent two dental prophylaxis. These individuals were in, both, the control and the treatment group. In the control group, an anesthetic protocol without xylazine was applied, whereas in the treatment group xylazine was applied. The second intervention (treatment group) had a wash-out period of at least 15 days. During the second dental prophylaxis, 5 blood samples were taken to measure the glucose by a spectrophotometric method. Through Anova, it was posible to verify that there were significant differences, resulting in a pvalue of 0.064 in the control group, and a p-value of <.001 in the treatment group. This means that the treatment presents significant differences by the use of xylazine, causing a hyperglicemic effect in healthy canines.en
dc.description.abstractLa xilacina es un fármaco muy usado en medicina veterinaria, en especial en especies mayores como equinos y bovinos. Actualmente este fármaco es usado en medicina de pequeñas especies, como son en perros y gatos, pero no hay suficiente información de los efectos que crea la xilacina en caninos sanos...es_ES
dc.format.extent41 p.es_ES
dc.language.isospaes_ES
dc.publisherQuito: Universidad de las Américas, 2019es_ES
dc.rightsopenAccesses_ES
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Ecuador*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/ec/*
dc.subjectFISIOLOGÍA VETERINARIAes_ES
dc.subjectHEMATOLOGÍA VETERINARIAes_ES
dc.subjectANESTESIOLOGÍAes_ES
dc.subjectVETERINARIA-XILACINAes_ES
dc.subjectCANINOSes_ES
dc.titleEvaluación de la glucemia con el método de espectrofotometría en pacientes caninos sanos bajo un protocolo anestésico basado en xilacina en la Clínica Veterinaria Vetcarecenteres_ES
dc.typebachelorThesises_ES
Aparece en las colecciones: Medicina Veterinaria y Zootecnia

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
UDLA-EC-TMVZ-2019-02.pdf1,35 MBAdobe PDFVisualizar/Abrir
Mostrar el registro sencillo del ítem


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons